Does TOFACITINIB Cause Product residue present? 130 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Product residue present have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
130
Reports of Product residue present with TOFACITINIB
0.1%
of all TOFACITINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product residue present From TOFACITINIB?
Of the 130 reports, 10 (7.7%) required hospitalization.
Is Product residue present Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Product residue present?
LEVODOPA (534)
UPADACITINIB (442)
ESTRADIOL (225)
POTASSIUM (183)
BUDESONIDE (168)
MESALAMINE (156)
MINOXIDIL (151)
FEXOFENADINE\PSEUDOEPHEDRINE (149)
BUPROPION (123)
METFORMIN (122)
Which TOFACITINIB Alternatives Have Lower Product residue present Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN